WO2023046605 - ENHANCED SYSTEM FOR TREATING A BIOTECHNOLOGICAL FLUID USING AN ADAPTIVE SOFTWARE
National phase entry:
Publication Number
WO/2023/046605
Publication Date
30.03.2023
International Application No.
PCT/EP2022/075874
International Filing Date
19.09.2022
Title **
[English]
ENHANCED SYSTEM FOR TREATING A BIOTECHNOLOGICAL FLUID USING AN ADAPTIVE SOFTWARE
[French]
SYSTÈME AMÉLIORÉ DE TRAITEMENT D'UN FLUIDE BIOTECHNOLOGIQUE À L'AIDE D'UN LOGICIEL ADAPTATIF
Applicants **
MERCK PATENT GMBH
Inventors
EBERHARD, Philippe
REINBIGLER, Rene
DUBRET, Denis
MILLER, Steven
Priority Data
21306311.8
22.09.2021
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2267 | |
| EPO | Filing, Examination, Granting | 9165 | |
| Japan | Filing, Examination, Granting | 2140 | |
| South Korea | Filing, Examination, Granting | 1983 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
20,295
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present application relates to biotechnological fluid treating, such as biopharmaceutical liquids in order to obtain products such as monoclonal antibodies, vaccines or recombinant proteins, and particularly to a system for treating a biotechnical fluid, having a bioprocess machine and at least one bioprocess machine helper, configured to connect to each other and each comprising a controller, in turn comprising a machine-to-machine communication tool configured for connecting to a network, wherein parts of the bioprocess machine helper are simulated and used to enhance the behaviour of the disclosed system.[French]
La présente invention concerne le traitement biotechnologique de fluides, tels que des liquides biopharmaceutiques afin d'obtenir des produits tels que des anticorps monoclonaux, des vaccins ou des protéines recombinées, et en particulier un système de traitement d'un fluide biotechnologique, ayant une machine de bioprocédé et au moins un auxiliaire de machine de bioprocédé, configurés pour se connecter l'un à l'autre et comprenant chacun un dispositif de commande, comprenant à son tour un outil de communication de machine à machine configuré pour se connecter à un réseau, des parties de l'auxiliaire de machine de bioprocédé étant simulées et utilisées pour améliorer le comportement du système décrit.